Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000262 · ClinicalTrials.gov registry record · NA

Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT00000262: Completed NA study, sponsored by University of Chicago.

NCT00000262 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000262, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.

Primary Outcome

Inhalation was for 68 min divided into 4 blocks with nitrous oxide added during either block 2 or block 4

Interventions

  • OTHER Placebo
  • DRUG 30% Nitrous oxide
  • DRUG 0.4% Sevoflurane
  • DRUG 0.2% sevoflurane

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 1996-11
Est. Completion 1999-02
Phase NA
University of Chicago

796 total trials

What the finished NCT00000262 record still lists

NCT00000262 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT00000262 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00000262 about?

NCT00000262 is a clinical study titled "Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14". The purpose of this study is to determine the effects of combined sevoflurane and nitrous oxide inhalation on mood, psychomotor performance, and the pain response in humans.

What is the current status of trial NCT00000262?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 1996-11. Estimated completion is 1999-02.

What interventions are being tested in trial NCT00000262?

The interventions under investigation include: Placebo (OTHER), 30% Nitrous oxide (DRUG), 0.4% Sevoflurane (DRUG), 0.2% sevoflurane (DRUG).

Who is sponsoring clinical trial NCT00000262?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00000262's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00000262, the US trial registry maintained by the National Library of Medicine. NCT00000262 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.